Literature DB >> 23810490

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.

J Compston1, C Bowring, A Cooper, C Cooper, C Davies, R Francis, J A Kanis, D Marsh, E V McCloskey, D M Reid, P Selby.   

Abstract

Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  FRAX; Fracture; Guideline; Osteoporosis

Mesh:

Substances:

Year:  2013        PMID: 23810490     DOI: 10.1016/j.maturitas.2013.05.013

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  89 in total

Review 1.  Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Authors:  Robert A Adler; Ghada El-Hajj Fuleihan; Douglas C Bauer; Pauline M Camacho; Bart L Clarke; Gregory A Clines; Juliet E Compston; Matthew T Drake; Beatrice J Edwards; Murray J Favus; Susan L Greenspan; Ross McKinney; Robert J Pignolo; Deborah E Sellmeyer
Journal:  J Bone Miner Res       Date:  2016-01       Impact factor: 6.741

2.  Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.

Authors:  E V McCloskey; H Johansson; N C Harvey; J Compston; J A Kanis
Journal:  Osteoporos Int       Date:  2016-07-20       Impact factor: 4.507

3.  High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.

Authors:  H Sato; N Kondo; T Nakatsue; Y Wada; J Fujisawa; J J Kazama; T Kuroda; Y Suzuki; M Nakano; N Endo; I Narita
Journal:  Osteoporos Int       Date:  2017-04-13       Impact factor: 4.507

4.  Serum CCL11 level is associated with radiographic spinal damage in patients with ankylosing spondylitis.

Authors:  Dong Hyun Sohn; Hoim Jeong; Jong Seong Roh; Han-Na Lee; Eunsung Kim; Jung Hee Koh; Seung-Geun Lee
Journal:  Rheumatol Int       Date:  2018-05-30       Impact factor: 2.631

5.  Implementation of a standardized protocol to manage elderly patients with low energy pelvic fractures: can service improvement be expected?

Authors:  Nikolaos K Kanakaris; Tess Greven; Robert M West; Arie B Van Vugt; Peter V Giannoudis
Journal:  Int Orthop       Date:  2017-07-21       Impact factor: 3.075

Review 6.  Osteoporosis diagnosis in men: the T-score controversy revisited.

Authors:  Neil Binkley; Robert Adler; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

7.  FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.

Authors:  R C Hamdy; E Seier; K Whalen; W A Clark; K Hicks; T B Piggee
Journal:  Osteoporos Int       Date:  2018-02-03       Impact factor: 4.507

8.  The Limited Clinical Utility of Testosterone, Estradiol, and Sex Hormone Binding Globulin Measurements in the Prediction of Fracture Risk and Bone Loss in Older Men.

Authors:  Eric S Orwoll; Jodi Lapidus; Patty Y Wang; Liesbeth Vandenput; Andrew Hoffman; Howard A Fink; Gail A Laughlin; Maria Nethander; Östen Ljunggren; Andreas Kindmark; Mattias Lorentzon; Magnus K Karlsson; Dan Mellström; Anthony Kwok; Sundeep Khosla; Timothy Kwok; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2016-11-14       Impact factor: 6.741

Review 9.  Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Authors:  Jordi Bover; Lucía Bailone; Víctor López-Báez; Silvia Benito; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal:  J Nephrol       Date:  2017-04-21       Impact factor: 3.902

Review 10.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.